Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Predictors of COVID-19 outcome in Parkinson's disease
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Predictors of COVID-19 outcome in Parkinson's disease
Creator
Alimonti, Dario
Alonso-Canovas, Araceli
Canesi, Margherita
Dallocchio, Carlo
Elia, Antonio
Fasano, Alfonso
Parkinson's Disease, In
Pezzoli, Gianni
Program, Edmond
Shulman, Gloria
Sorbera, Chiara
Source
Elsevier; Medline; PMC
abstract
INTRODUCTION: Specific pre-existing medical conditions (e.g. hypertension or obesity), advanced age and male sex appear linked to more severe manifestations of SARS Co-V2 infection, thus raising the question of whether Parkinson's disease (PD) poses an increased risk of morbidity and mortality in COVID-19 patients. METHODS: In order to describe the outcome of COVID-19 in multi-centre a cohort of PD patients and explore its potential predictors, we gathered the clinical information of 117 community-dwelling patients with COVID-19 followed in 21 tertiary centres in Italy, Iran, Spain, and the UK. RESULTS: Overall mortality was 19.7%, with a significant effect of co-occurrence of dementia, hypertension, and PD duration. CONCLUSIONS: The frailty caused by advanced PD poses an increased risk of mortality during COVID-19.
has issue date
2020-08-13
(
xsd:dateTime
)
bibo:doi
10.1016/j.parkreldis.2020.08.012
bibo:pmid
32827969
has license
no-cc
sha1sum (hex)
f958e05d4e649da1fb2d2b2fa1ad7481bc488494
schema:url
https://doi.org/10.1016/j.parkreldis.2020.08.012
resource representing a document's title
Predictors of COVID-19 outcome in Parkinson's disease
has PubMed Central identifier
PMC7424315
has PubMed identifier
32827969
schema:publication
Parkinsonism Relat Disord
resource representing a document's body
covid:f958e05d4e649da1fb2d2b2fa1ad7481bc488494#body_text
is
schema:about
of
named entity 'poses'
named entity 'male'
named entity 'hypertension'
named entity 'disease'
named entity 'PATIENTS'
named entity 'obesity'
named entity 'manifestations'
named entity 'raising'
named entity 'COVID-19'
named entity 'pre-existing medical conditions'
named entity 'Parkinson's disease'
named entity 'hypertension'
named entity 'SARS'
named entity 'pre-existing medical conditions'
named entity 'morbidity'
named entity 'COVID'
named entity 'decompensate'
named entity 'nursing homes'
named entity 'hypertension'
named entity 'Parkinsonism'
named entity 'central nervous'
named entity 'acute respiratory distress syndrome'
named entity 'dopaminergic'
named entity 'case-controlled'
named entity 'dopamine agonists'
named entity 'Severe acute respiratory syndrome coronavirus 2'
named entity 'COVID'
named entity 'infection'
named entity 'FDA'
named entity 'mouse models'
named entity 'lysosomal'
named entity 'SARS'
named entity 'SARS-CoV2'
named entity 'medical care'
named entity 'neurological disorders'
named entity 'SARS'
named entity 'life expectancy'
named entity 'COVID'
named entity 'Enzyme'
named entity 'supine hypertension'
named entity 'Parkinsonism'
named entity 'dopa decarboxylase'
named entity 'London'
named entity 'Angiotensin'
named entity 'morbidity'
named entity 'Italian'
named entity 'China'
named entity 'Drug repurposing'
named entity 'ethical standards'
named entity 'Wuhan'
named entity 'COVID-19'
named entity 'non-parametric'
named entity 'virus'
named entity 'receptor'
named entity 'sepsis'
named entity 'observational studies'
named entity 'Italian'
named entity 'comorbidities'
named entity 'influenza'
named entity 'neurologist'
named entity 'motor function'
named entity 'Dehydration'
named entity 'ANOVA'
named entity 'dysautonomia'
named entity 'FDA'
named entity 'L-dopa'
named entity 'Dopamine agonists'
named entity 'neurologic'
named entity 'Respiratory Failure'
named entity 'gene'
named entity 'olfactory pathways'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 3
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software